Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.

Zhu Q, Lu B, McTamney P, Palaszynski S, Diallo S, Ren K, Ulbrandt ND, Kallewaard N, Wang W, Fernandes F, Wong S, Svabek C, Moldt B, Esser MT, Jing H, Suzich JA.

J Infect Dis. 2018 Jul 13;218(4):572-580. doi: 10.1093/infdis/jiy189.

PMID:
29617879
2.

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants.

Zhu Q, McLellan JS, Kallewaard NL, Ulbrandt ND, Palaszynski S, Zhang J, Moldt B, Khan A, Svabek C, McAuliffe JM, Wrapp D, Patel NK, Cook KE, Richter BWM, Ryan PC, Yuan AQ, Suzich JA.

Sci Transl Med. 2017 May 3;9(388). pii: eaaj1928. doi: 10.1126/scitranslmed.aaj1928.

PMID:
28469033
3.

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

Dall'Acqua WF, Woods RM, Ward ES, Palaszynski SR, Patel NK, Brewah YA, Wu H, Kiener PA, Langermann S.

J Immunol. 2002 Nov 1;169(9):5171-80.

4.

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Langermann S, Möllby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S.

J Infect Dis. 2000 Feb;181(2):774-8.

PMID:
10669375
5.

Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.

Palaszynski S, Pinkner J, Leath S, Barren P, Auguste CG, Burlein J, Hultgren S, Langermann S.

Dev Biol Stand. 1998;92:117-22.

PMID:
9554264
6.

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ.

Science. 1997 Apr 25;276(5312):607-11.

7.

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi.

Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S.

Nature. 1994 Dec 8;372(6506):552-5.

PMID:
7990928
8.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK.

J Exp Med. 1994 Dec 1;180(6):2277-86.

9.

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG.

J Exp Med. 1993 Jul 1;178(1):197-209.

10.

A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.

Schulof RS, Lloyd MJ, Cleary PA, Palaszynski SR, Mai DA, Cox JW Jr, Alabaster O, Goldstein AL.

J Biol Response Mod. 1985 Apr;4(2):147-58.

PMID:
3998766
11.

T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.

Schulof RS, Chorba TL, Cleary PA, Palaszynski SR, Alabaster O, Goldstein AL.

Cancer. 1985 Mar 1;55(5):974-83.

PMID:
3155644

Supplemental Content

Loading ...
Support Center